Results 31 to 40 of about 9,180 (202)

A Systematic Review of Immunological Studies of Erythema Nodosum Leprosum. [PDF]

open access: yes, 2017
Erythema nodosum leprosum (ENL) is a painful inflammatory complication of leprosy occurring in 50% of lepromatous leprosy patients and 5-10% of borderline lepromatous patients.
Abalos   +228 more
core   +1 more source

Leprosy in families: Clinicoepidemiological profile from a tertiary care centre

open access: yesIndian Dermatology Online Journal, 2017
Objectives: The primary objective of this retrospective study was to determine the prevalence of leprosy in families, and the secondary objective was to study the clinicoepidemiological features of leprosy in families.
Sukumaran Pradeep Nair
doaj   +1 more source

Verrucous lepromatous leprosy: a rare form of presentation - Report on two cases [PDF]

open access: yesAnais Brasileiros de Dermatologia, 2014
Leprosy skin lesions are described as hypochromic or erythematous macules, pale erythematous or reddish-brown plaques, papules, nodules, and diffuse cutaneous infiltration, depending on the clinical form of the disease. They may be accompanied by hypo or
Marcelo Zanolli Medeiros   +5 more
doaj   +1 more source

Borderline lepromatous leprosy: A case report

open access: yesAsian Pacific Journal of Tropical Medicine
Rationale: Lepromatous leprosy can have many atypical presentations, obscuring early diagnosis. We present a case of lepromatous leprosy, presenting with atypical features, which made a diagnostic dilemma.
Nilshan Fernando   +3 more
doaj   +1 more source

Potential of AKR1B10 as a Biomarker and Therapeutic Target in Type 2 Leprosy Reaction

open access: yesFrontiers in Medicine, 2018
The AKR1B10 (aldo-keto reductase family 1 member B10) gene has important functions in carcinogen-induced neoplasia. AKR1B10 is also expressed in type 2 reaction leprosy patients (R2).
Cleverson T. Soares   +5 more
doaj   +1 more source

Skin microbiota: a source of disease or defence?

open access: yes, 2008
Microbes found on the skin are usually regarded as pathogens, potential pathogens or innocuous symbiotic organisms. Advances in microbiology and immunology are revising our understanding of the molecular mechanisms of microbial virulence and the specific
Cogen, AL, Gallo, RL, Nizet, V
core   +1 more source

Diffuse lepromatous leprosy caused by dual infection of mycobacterium leprae and mycobacterium lepromatosis: A case report

open access: yesDermatology Reports, 2019
M. lepromatosis is the dominant cause of leprosy in Mexico and it co-exists with M. leprae in endemic areas as the once elusive second cause of leprosy. A 41-year-old Madurese woman came with multiple ulcer on her legs, hands and buttock. The ulcers were
Ridha Ramadina Widiatma, Hari Sukanto
doaj   +1 more source

Skeletal Evidence for Leprosy in India by the Second Millenium B.C. [PDF]

open access: yes, 2009
Leprosy is a chronic infectious disease caused by _Mycobacterium leprae_ that affects almost 500,000 people worldwide^1^. The timing of first infection, geographic origin, and pattern of transmission of the disease are unknown^1-3^.
Gwendolyn Robbins   +6 more
core   +1 more source

Demyelinating Leprosy Neuropathy: An Unusual and Misleading Electrophysiological Pattern

open access: yesMuscle &Nerve, EarlyView.
ABSTRACT Introduction/Aims Peripheral neuropathy, especially mononeuropathy multiplex, is a frequent manifestation of leprosy. Electrodiagnostic studies (EDX) usually show predominant axonal involvement. In this study, we report patients with prominent demyelinating abnormalities consistent with the diagnosis of chronic inflammatory demyelinating ...
Cendrine Foucard   +4 more
wiley   +1 more source

De Novo Histoid Leprosy in an Elderly: A Case Report and Review of the Literature

open access: yesCase Reports in Pathology, 2012
Histoid leprosy, an uncommon variant of lepromatous leprosy, develops usually as relapse in lepromatous patients who are on dapsone monotherapy, but uncommonly arises de novo.
Deepak Dimri, Bhawna Sethi, Yogesh Kumar
doaj   +1 more source

Home - About - Disclaimer - Privacy